nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—STK10—renal vein—abdominal aortic aneurysm	0.0968	0.188	CbGeAlD
Sorafenib—STK10—renal artery—abdominal aortic aneurysm	0.065	0.126	CbGeAlD
Sorafenib—KDR—hindlimb—abdominal aortic aneurysm	0.0185	0.0358	CbGeAlD
Sorafenib—FLT3—blood plasma—abdominal aortic aneurysm	0.0142	0.0276	CbGeAlD
Sorafenib—FLT1—artery—abdominal aortic aneurysm	0.0134	0.026	CbGeAlD
Sorafenib—KDR—artery—abdominal aortic aneurysm	0.0113	0.022	CbGeAlD
Sorafenib—RALBP1—blood plasma—abdominal aortic aneurysm	0.0106	0.0205	CbGeAlD
Sorafenib—CDK7—connective tissue—abdominal aortic aneurysm	0.0105	0.0204	CbGeAlD
Sorafenib—FLT1—blood plasma—abdominal aortic aneurysm	0.0101	0.0195	CbGeAlD
Sorafenib—STK10—blood plasma—abdominal aortic aneurysm	0.00952	0.0185	CbGeAlD
Sorafenib—UGT1A1—blood plasma—abdominal aortic aneurysm	0.00899	0.0174	CbGeAlD
Sorafenib—HIPK3—connective tissue—abdominal aortic aneurysm	0.00892	0.0173	CbGeAlD
Sorafenib—KDR—blood plasma—abdominal aortic aneurysm	0.0085	0.0165	CbGeAlD
Sorafenib—CSF1R—blood plasma—abdominal aortic aneurysm	0.0083	0.0161	CbGeAlD
Sorafenib—HIPK3—kidney—abdominal aortic aneurysm	0.00759	0.0147	CbGeAlD
Sorafenib—FLT3—connective tissue—abdominal aortic aneurysm	0.00758	0.0147	CbGeAlD
Sorafenib—KIT—blood plasma—abdominal aortic aneurysm	0.00753	0.0146	CbGeAlD
Sorafenib—MKNK2—connective tissue—abdominal aortic aneurysm	0.00623	0.0121	CbGeAlD
Sorafenib—RET—connective tissue—abdominal aortic aneurysm	0.00608	0.0118	CbGeAlD
Sorafenib—UGT1A9—kidney—abdominal aortic aneurysm	0.00594	0.0115	CbGeAlD
Sorafenib—ABCC4—blood plasma—abdominal aortic aneurysm	0.00586	0.0114	CbGeAlD
Sorafenib—FLT1—connective tissue—abdominal aortic aneurysm	0.00535	0.0104	CbGeAlD
Sorafenib—RAF1—connective tissue—abdominal aortic aneurysm	0.00532	0.0103	CbGeAlD
Sorafenib—RET—kidney—abdominal aortic aneurysm	0.00518	0.01	CbGeAlD
Sorafenib—PDGFRA—connective tissue—abdominal aortic aneurysm	0.00502	0.00973	CbGeAlD
Sorafenib—CYP2C19—blood plasma—abdominal aortic aneurysm	0.00487	0.00945	CbGeAlD
Sorafenib—RALBP1—kidney—abdominal aortic aneurysm	0.00479	0.00929	CbGeAlD
Sorafenib—FLT1—kidney—abdominal aortic aneurysm	0.00456	0.00884	CbGeAlD
Sorafenib—RAF1—kidney—abdominal aortic aneurysm	0.00453	0.00879	CbGeAlD
Sorafenib—KDR—connective tissue—abdominal aortic aneurysm	0.00453	0.00878	CbGeAlD
Sorafenib—FGFR1—spinal cord—abdominal aortic aneurysm	0.0045	0.00873	CbGeAlD
Sorafenib—CSF1R—connective tissue—abdominal aortic aneurysm	0.00442	0.00857	CbGeAlD
Sorafenib—STK10—kidney—abdominal aortic aneurysm	0.00431	0.00837	CbGeAlD
Sorafenib—MAP3K7—spinal cord—abdominal aortic aneurysm	0.00426	0.00827	CbGeAlD
Sorafenib—CYP2C8—blood plasma—abdominal aortic aneurysm	0.00425	0.00825	CbGeAlD
Sorafenib—MKNK2—spinal cord—abdominal aortic aneurysm	0.00413	0.00801	CbGeAlD
Sorafenib—MKNK1—spinal cord—abdominal aortic aneurysm	0.00408	0.00791	CbGeAlD
Sorafenib—UGT1A1—kidney—abdominal aortic aneurysm	0.00407	0.0079	CbGeAlD
Sorafenib—RET—spinal cord—abdominal aortic aneurysm	0.00403	0.00781	CbGeAlD
Sorafenib—KIT—connective tissue—abdominal aortic aneurysm	0.00401	0.00778	CbGeAlD
Sorafenib—CYP1A2—blood plasma—abdominal aortic aneurysm	0.00398	0.00772	CbGeAlD
Sorafenib—PDGFRB—connective tissue—abdominal aortic aneurysm	0.00392	0.0076	CbGeAlD
Sorafenib—KDR—kidney—abdominal aortic aneurysm	0.00385	0.00747	CbGeAlD
Sorafenib—CYP3A5—blood plasma—abdominal aortic aneurysm	0.00384	0.00744	CbGeAlD
Sorafenib—CYP2B6—blood plasma—abdominal aortic aneurysm	0.00382	0.0074	CbGeAlD
Sorafenib—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00378	0.00733	CbGeAlD
Sorafenib—RALBP1—spinal cord—abdominal aortic aneurysm	0.00373	0.00724	CbGeAlD
Sorafenib—FLT1—spinal cord—abdominal aortic aneurysm	0.00355	0.00688	CbGeAlD
Sorafenib—RAF1—spinal cord—abdominal aortic aneurysm	0.00353	0.00684	CbGeAlD
Sorafenib—EPHB6—spinal cord—abdominal aortic aneurysm	0.00351	0.0068	CbGeAlD
Sorafenib—KIT—kidney—abdominal aortic aneurysm	0.00341	0.00662	CbGeAlD
Sorafenib—PDGFRB—kidney—abdominal aortic aneurysm	0.00333	0.00647	CbGeAlD
Sorafenib—PDGFRA—spinal cord—abdominal aortic aneurysm	0.00333	0.00645	CbGeAlD
Sorafenib—MAP2K5—spinal cord—abdominal aortic aneurysm	0.003	0.00582	CbGeAlD
Sorafenib—KDR—spinal cord—abdominal aortic aneurysm	0.003	0.00582	CbGeAlD
Sorafenib—CSF1R—spinal cord—abdominal aortic aneurysm	0.00293	0.00568	CbGeAlD
Sorafenib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00288	0.00559	CbGeAlD
Sorafenib—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00283	0.0055	CbGeAlD
Sorafenib—KIT—spinal cord—abdominal aortic aneurysm	0.00266	0.00516	CbGeAlD
Sorafenib—ABCC4—kidney—abdominal aortic aneurysm	0.00266	0.00515	CbGeAlD
Sorafenib—PDGFRB—spinal cord—abdominal aortic aneurysm	0.0026	0.00504	CbGeAlD
Sorafenib—ABCC2—kidney—abdominal aortic aneurysm	0.00257	0.00498	CbGeAlD
Sorafenib—HTR2C—spinal cord—abdominal aortic aneurysm	0.00219	0.00425	CbGeAlD
Sorafenib—ABCB1—blood plasma—abdominal aortic aneurysm	0.00204	0.00395	CbGeAlD
Sorafenib—CYP2C8—kidney—abdominal aortic aneurysm	0.00193	0.00374	CbGeAlD
Sorafenib—CYP3A5—kidney—abdominal aortic aneurysm	0.00174	0.00337	CbGeAlD
Sorafenib—CYP2B6—kidney—abdominal aortic aneurysm	0.00173	0.00335	CbGeAlD
Sorafenib—ABCG2—spinal cord—abdominal aortic aneurysm	0.00146	0.00283	CbGeAlD
Sorafenib—CYP3A4—kidney—abdominal aortic aneurysm	0.00131	0.00253	CbGeAlD
Sorafenib—CYP2D6—kidney—abdominal aortic aneurysm	0.00128	0.00249	CbGeAlD
Sorafenib—ABCB1—kidney—abdominal aortic aneurysm	0.000924	0.00179	CbGeAlD
Sorafenib—ABCB1—spinal cord—abdominal aortic aneurysm	0.00072	0.0014	CbGeAlD
Sorafenib—PDGFRA—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000156	0.000322	CbGpPWpGaD
Sorafenib—CDK7—Disease—SERPINE1—abdominal aortic aneurysm	0.000155	0.00032	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000155	0.000319	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000154	0.000318	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000152	0.000315	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000152	0.000314	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000152	0.000313	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00015	0.00031	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000149	0.000307	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000147	0.000303	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000147	0.000303	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000145	0.0003	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000145	0.000299	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000144	0.000297	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000144	0.000297	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000144	0.000297	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000143	0.000296	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000143	0.000296	CbGpPWpGaD
Sorafenib—BRAF—Disease—APOE—abdominal aortic aneurysm	0.000143	0.000295	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000143	0.000294	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000142	0.000294	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000141	0.000291	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000141	0.000291	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00014	0.00029	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.00014	0.000288	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000139	0.000286	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—LDLR—abdominal aortic aneurysm	0.000138	0.000286	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000138	0.000285	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000138	0.000285	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000137	0.000282	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000136	0.000281	CbGpPWpGaD
Sorafenib—CDK7—Disease—PTGS2—abdominal aortic aneurysm	0.000135	0.000279	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000135	0.000279	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000134	0.000276	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000134	0.000276	CbGpPWpGaD
Sorafenib—BRAF—Disease—NOS2—abdominal aortic aneurysm	0.000133	0.000275	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000132	0.000273	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000132	0.000273	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000131	0.000271	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000131	0.000271	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000131	0.00027	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000131	0.00027	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000131	0.00027	CbGpPWpGaD
Sorafenib—KIT—Disease—APOE—abdominal aortic aneurysm	0.00013	0.000269	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000129	0.000267	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000128	0.000264	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000125	0.000259	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000125	0.000259	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000125	0.000258	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000125	0.000258	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000125	0.000258	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000124	0.000256	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APOE—abdominal aortic aneurysm	0.000124	0.000255	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APOE—abdominal aortic aneurysm	0.000123	0.000254	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000123	0.000254	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000123	0.000253	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000122	0.000252	CbGpPWpGaD
Sorafenib—KIT—Disease—NOS2—abdominal aortic aneurysm	0.000121	0.00025	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000121	0.000249	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00012	0.000248	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00012	0.000247	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000118	0.000244	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000118	0.000243	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000118	0.000243	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000118	0.000243	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000118	0.000243	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—AAAS—abdominal aortic aneurysm	0.000117	0.000242	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000117	0.000241	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000115	0.000238	CbGpPWpGaD
Sorafenib—FGFR1—Disease—NOS2—abdominal aortic aneurysm	0.000115	0.000238	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—NOS2—abdominal aortic aneurysm	0.000115	0.000237	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.000115	0.000236	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000114	0.000235	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000113	0.000233	CbGpPWpGaD
Sorafenib—BRAF—Disease—SERPINE1—abdominal aortic aneurysm	0.000112	0.000232	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000112	0.000231	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000112	0.00023	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APOE—abdominal aortic aneurysm	0.000111	0.000229	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000109	0.000226	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000108	0.000223	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000108	0.000222	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000106	0.000219	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000105	0.000218	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000105	0.000217	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000105	0.000217	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—NOS2—abdominal aortic aneurysm	0.000103	0.000214	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000103	0.000213	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000103	0.000213	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000103	0.000212	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—LDLR—abdominal aortic aneurysm	0.000102	0.000211	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000102	0.000211	CbGpPWpGaD
Sorafenib—KIT—Disease—SERPINE1—abdominal aortic aneurysm	0.000102	0.000211	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000101	0.000209	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000101	0.000209	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000101	0.000208	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.0001	0.000207	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.0001	0.000207	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APOE—abdominal aortic aneurysm	0.0001	0.000207	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.0001	0.000206	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	9.92e-05	0.000205	CbGpPWpGaD
Sorafenib—RAF1—Disease—APOE—abdominal aortic aneurysm	9.89e-05	0.000204	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.88e-05	0.000204	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	9.86e-05	0.000204	CbGpPWpGaD
Sorafenib—BRAF—Disease—PTGS2—abdominal aortic aneurysm	9.8e-05	0.000202	CbGpPWpGaD
Sorafenib—FGFR1—Disease—SERPINE1—abdominal aortic aneurysm	9.69e-05	0.0002	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—SERPINE1—abdominal aortic aneurysm	9.67e-05	0.0002	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	9.58e-05	0.000198	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.47e-05	0.000195	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—AGT—abdominal aortic aneurysm	9.3e-05	0.000192	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—AGT—abdominal aortic aneurysm	9.3e-05	0.000192	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—NFKB1—abdominal aortic aneurysm	9.3e-05	0.000192	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.22e-05	0.00019	CbGpPWpGaD
Sorafenib—RAF1—Disease—NOS2—abdominal aortic aneurysm	9.22e-05	0.00019	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	9.17e-05	0.000189	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APOE—abdominal aortic aneurysm	9.11e-05	0.000188	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APOE—abdominal aortic aneurysm	9.11e-05	0.000188	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	8.99e-05	0.000186	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.96e-05	0.000185	CbGpPWpGaD
Sorafenib—KIT—Disease—PTGS2—abdominal aortic aneurysm	8.92e-05	0.000184	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	8.85e-05	0.000183	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—AGT—abdominal aortic aneurysm	8.83e-05	0.000182	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—AGT—abdominal aortic aneurysm	8.81e-05	0.000182	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—SERPINE1—abdominal aortic aneurysm	8.71e-05	0.00018	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—AGT—abdominal aortic aneurysm	8.69e-05	0.000179	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—AGT—abdominal aortic aneurysm	8.69e-05	0.000179	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—AGTR1—abdominal aortic aneurysm	8.67e-05	0.000179	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	8.66e-05	0.000179	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APOE—abdominal aortic aneurysm	8.65e-05	0.000179	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	8.64e-05	0.000178	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APOE—abdominal aortic aneurysm	8.63e-05	0.000178	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—APOE—abdominal aortic aneurysm	8.52e-05	0.000176	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—APOE—abdominal aortic aneurysm	8.52e-05	0.000176	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CCL2—abdominal aortic aneurysm	8.51e-05	0.000176	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.5e-05	0.000175	CbGpPWpGaD
Sorafenib—FGFR1—Disease—PTGS2—abdominal aortic aneurysm	8.46e-05	0.000175	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—PTGS2—abdominal aortic aneurysm	8.44e-05	0.000174	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.42e-05	0.000174	CbGpPWpGaD
Sorafenib—KIT—Immune System—NFKB1—abdominal aortic aneurysm	8.38e-05	0.000173	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—NFKB1—abdominal aortic aneurysm	8.38e-05	0.000173	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	8.37e-05	0.000173	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	8.2e-05	0.000169	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	8.14e-05	0.000168	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	8.07e-05	0.000167	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—NFKB1—abdominal aortic aneurysm	7.96e-05	0.000164	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—NFKB1—abdominal aortic aneurysm	7.94e-05	0.000164	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—AGT—abdominal aortic aneurysm	7.93e-05	0.000164	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.93e-05	0.000164	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.86e-05	0.000162	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APOE—abdominal aortic aneurysm	7.77e-05	0.000161	CbGpPWpGaD
Sorafenib—RAF1—Disease—SERPINE1—abdominal aortic aneurysm	7.76e-05	0.00016	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.73e-05	0.00016	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	7.73e-05	0.00016	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.66e-05	0.000158	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.66e-05	0.000158	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—PTGS2—abdominal aortic aneurysm	7.61e-05	0.000157	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—AGT—abdominal aortic aneurysm	7.57e-05	0.000156	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	7.55e-05	0.000156	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APOE—abdominal aortic aneurysm	7.41e-05	0.000153	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	7.38e-05	0.000152	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—AGT—abdominal aortic aneurysm	7.31e-05	0.000151	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.27e-05	0.00015	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.25e-05	0.00015	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.25e-05	0.00015	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	7.23e-05	0.000149	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.17e-05	0.000148	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOE—abdominal aortic aneurysm	7.16e-05	0.000148	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.15e-05	0.000148	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.15e-05	0.000148	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—NFKB1—abdominal aortic aneurysm	7.15e-05	0.000148	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	7.15e-05	0.000148	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	7.11e-05	0.000147	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—AGT—abdominal aortic aneurysm	7.07e-05	0.000146	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.07e-05	0.000146	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	7.05e-05	0.000146	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	7e-05	0.000145	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.99e-05	0.000144	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOE—abdominal aortic aneurysm	6.93e-05	0.000143	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	6.9e-05	0.000142	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	6.9e-05	0.000142	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.79e-05	0.00014	CbGpPWpGaD
Sorafenib—RAF1—Disease—PTGS2—abdominal aortic aneurysm	6.78e-05	0.00014	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.77e-05	0.00014	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.53e-05	0.000135	CbGpPWpGaD
Sorafenib—RAF1—Immune System—NFKB1—abdominal aortic aneurysm	6.37e-05	0.000132	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.23e-05	0.000129	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	6.16e-05	0.000127	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—AGT—abdominal aortic aneurysm	6.1e-05	0.000126	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.1e-05	0.000126	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.08e-05	0.000125	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	6.02e-05	0.000124	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.02e-05	0.000124	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.01e-05	0.000124	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOE—abdominal aortic aneurysm	5.98e-05	0.000123	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.96e-05	0.000123	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PTGS2—abdominal aortic aneurysm	5.84e-05	0.000121	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PTGS2—abdominal aortic aneurysm	5.84e-05	0.000121	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.82e-05	0.00012	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.82e-05	0.00012	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	5.62e-05	0.000116	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.48e-05	0.000113	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.48e-05	0.000113	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.44e-05	0.000112	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.42e-05	0.000112	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.42e-05	0.000112	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—AGT—abdominal aortic aneurysm	5.41e-05	0.000112	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	5.32e-05	0.00011	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOE—abdominal aortic aneurysm	5.3e-05	0.000109	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	5.28e-05	0.000109	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.2e-05	0.000107	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.19e-05	0.000107	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	5.18e-05	0.000107	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.14e-05	0.000106	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.13e-05	0.000106	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.03e-05	0.000104	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	4.95e-05	0.000102	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTGS2—abdominal aortic aneurysm	4.91e-05	0.000101	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	4.8e-05	9.91e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.69e-05	9.69e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.67e-05	9.65e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	4.65e-05	9.6e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.62e-05	9.54e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	4.58e-05	9.45e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	4.49e-05	9.26e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.46e-05	9.2e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.41e-05	9.1e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.16e-05	8.6e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.12e-05	8.51e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	4.09e-05	8.44e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	4e-05	8.27e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	3.99e-05	8.23e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	3.91e-05	8.07e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	3.76e-05	7.76e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	3.73e-05	7.69e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	3.68e-05	7.6e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	3.65e-05	7.54e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTGS2—abdominal aortic aneurysm	3.63e-05	7.5e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.59e-05	7.42e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.56e-05	7.34e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	3.55e-05	7.33e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	3.18e-05	6.57e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	3.12e-05	6.44e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	3.07e-05	6.35e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	2.74e-05	5.66e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	2.68e-05	5.53e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	2.52e-05	5.21e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	2.5e-05	5.16e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.46e-05	5.07e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	2.41e-05	4.97e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	2.14e-05	4.41e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.65e-05	3.41e-05	CbGpPWpGaD
